Cure Tycoon

You are the new CEO of a real biotech. Every company in Cure Tycoon starts from its actual public numbers: its market value, its sales, and the drug programs it really has in trials (from ClinicalTrials.gov). Then the clock starts.

Your goal: treat as many patients as you can, and make it the best stock in pharma.

How it plays

• ⏱ Time runs. Quarters tick by on their own. Big calls stop the clock and land on your desk: fund the Phase 3 or partner it? Sell a program to the rival who wants it? Buy a card at auction? Every call shows the odds, the cost and what the market thinks it is worth.
• 🧪 Drugs make it or fail. Real pipelines, real historical success rates. Labs and skill cards tilt the odds; they never guarantee them.
• 📰 Breaking news. Pandemics, drug-pricing laws, an AI at the FDA. Three analysts tell you what will happen next. A year later you find out who was right.
• 📈 It never ends. The patient counter keeps climbing. Milestones at a thousand patients, a million, a billion. 28 rival companies play on the same clock, and they buy, sell and fail too.

Features

• 29 real companies, from small biotechs to big pharma. A new daily company each day: everyone plays the same one.
• A living patient counter that grows every second your drugs are on the market.
• Collectible skill cards (modalities, disease areas, deal-making) with real upkeep costs.
• A market-implied valuation: your share price moves the way analysts would move it.
• Plays in the browser, on desktop and on mobile. No account, no download.

Also at curetycoon.com

A game. It starts from real public data (company financials, ClinicalTrials.gov); forecasts, deals and news are fiction. Not affiliated with, or endorsed by, any company named. Not investment advice.